sb 216763 has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phyu, SM; Smith, TAD; Tseng, CC | 1 |
| Choi, J; Hwang, JJ; Jang, SJ; Kim, CS; Kim, HM; Lee, JH; Ro, S | 1 |
| Dong, J; Hung, MC; Jian, W; Meric-Bernstam, F; Mills, GB; Mondesire, WH; Peng, J; Zhang, H | 1 |
3 other study(ies) available for sb 216763 and Breast Neoplasms
| Article | Year |
|---|---|
CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Choline; Colorectal Neoplasms; Cytidine Diphosphate Choline; Enzyme Inhibitors; Female; Glucose; Glycogen Synthase Kinase 3; Humans; Indoles; Lipid Metabolism; Magnetic Resonance Spectroscopy; Maleimides; Phosphatidylcholines | 2019 |
CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Benzazepines; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cyclin D1; Female; Glycogen Synthase Kinase 3; Humans; Indoles; Lithium Chloride; Maleimides; Real-Time Polymerase Chain Reaction | 2013 |
Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Topics: Aminophenols; Antibiotics, Antineoplastic; Antimanic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cyclin D1; Cysteine Proteinase Inhibitors; Down-Regulation; Drug Resistance, Neoplasm; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Half-Life; Humans; Indoles; Leupeptins; Lithium Chloride; Maleimides; Mitochondria; NF-kappa B; Paclitaxel; Proteasome Inhibitors; Sirolimus | 2005 |